glp-1 addiction trials IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target GLP-1 medications get at the

Some may be managed by lowering your dose or behavioral modifications (e.g., eating smaller meals more frequently), but others can require immediate medical attention

Jessica Duncan, an obesity medicine physician and chief medical officer at the telehealth practice Ivim Health, who testified before the panel

"GLP-1 receptor agonists are medications that mimic a natural hormone in your body called glucagon-like peptide-1 [GLP-1]," explains Thomas Tsang, MD, MPH, Chief Medical Officer at Omada Health

Yet, symptomatology is highly variable across individuals, shaped by underlying neurobiological factors

J Bioenerget Biomembranes